Yıl: 2021 Cilt: 17 Sayı: 2 Sayfa Aralığı: 103 - 111 Metin Dili: İngilizce DOI: 10.4274/ejbh.galenos.2020.6154 İndeks Tarihi: 07-06-2021

Cytological Evaluation of Pathological Male Breast Lesions

Öz:
Objective: This study aimed to determine the cytodiagnostic spectrum of various male breast lesions, which were corroborated on histopathology asappropriate, to describe the process of the cytomorphology of some uncommon pathological lesions, and to discuss the reasons of their misdiagnoses.Materials and Methods: In this 8-year study, a total of 114 patients underwent fine needle aspiration cytology (FNAC). In a representative case, nippledischarge from an 8-month-old child was examined. Confirmatory histopathology was obtained in 38 cases only.Results: Gynecomastia was the most common (63.5%) male breast pathology. Invasive breast carcinoma of no special type was the most common variantof male breast malignancy. Half of the “gray zone” of cytological lesions was confirmed as cancer, but the rest were diagnosed as fibrocystic disease andintraductal papilloma. All cases with malignant cytology matched their corresponding histopathology. However, a tumor from an intraductal papillarycarcinoma was miscued as ductal carcinoma on previous FNAC.Conclusion: Cytological evaluation of male breast lesions provides highly sensitive and specific results with excellent histologic reproducibility. Thus, itshould be the ideal pretherapeutic diagnostic procedure for male breasts. However, some benign pathological conditions, which are particularly associatedwith epithelial hyperplasia, perplex the cytomorphologic scenario into the “gray zone.”
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Singh R, Anshu, Sharma SM, Gangane N. Spectrum of male breast lesions diagnosed by fine needle aspiration cytology: A 5-year experience at a tertiary care rural hospital in central India. Diagn Cytopathol 2012; 40: 113-117. (PMID: 22246926) [Crossref]
  • 2. Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B. Gynecomastia: Clinical evaluation and management. Indian J Endocrinol Metab 2014; 18: 150- 158. (PMID: 24741509) [Crossref]
  • 3. Chikaraddi SB, Krishnappa R, Deshmane V. Male breast cancers in Indian patients: Is it the same? Indian J Cancer 2012; 49: 272-276. (PMID: 23238143) [Crossref]
  • 4. Wauters CAP, Kooistra BW, de Kievit-van der Heijden IM, Strobbe LJA. Is cytology useful in the diagnostic workup of male breast lesions? A retrospective study over a 16-year period and review of the recent literature. Acta Cytol 2010; 54: 259-264. (PMID: 20518408) [Crossref]
  • 5. Rosa M, Masood S. Cytomorphology of male breast lesions: Diagnostic pitfalls and clinical implications. Diagn Cytopathol 2012; 40: 179-184. (PMID: 22246937) [Crossref]
  • 6. Al-Allak A, Govindarajulu S, Shere M, Ibrahim N, Sahu AK, Cawthorn SJ. Gynaecomastia: A decade of experience. Surgeon 2011; 9: 255-258. (PMID: 21843819) [Crossref]
  • 7. Jatav J, Gaur R, Pandit V, Jain B. Cytological evaluation of male breast lesions in greater Gwalior: A five year retrospective study. J Evid Based Med Heathc 2015; 2: 1359-1364. [Crossref]
  • 8. Johnson RE, Kermott CA, Murad MH. Gynecomastia - Evaluation and current treatment options. Ther Clin Risk Manag 2011; 7: 145-148. (PMID: 21479145) [Crossref]
  • 9. Chide PM, Nayak S, Kumbhalkar D. Role of fine needle aspiration cytology in male breast lesion: 4 year observational study. Int J Res Med Sci 2016; 4: 3945-3950. [Crossref]
  • 10. Gochhait D, Dehuri P, Umamahesweran S, Kamat R. Breast abscess mimicking breast carcinoma in male. J Midlife Health 2018; 9: 39-40. (PMID: 29628728) [Crossref]
  • 11. Iuanow E, Kettler M, Slanetz PJ. Spectrum of disease in the male breast. AJR Am J Roentgenol 2011; 196: W247-W259. (PMID: 21343472) [Crossref]
  • 12. Sathiyamoorthy R, Kalaivani M, Aggarwal P, Gupta SK. Prevalence of pulmonary tuberculosis in India: A systematic review and meta-analysis. Lung India 2020; 37: 45-52. (PMID: 31898620) [Crossref]
  • 13. Quaglio G, Pizzol D, Bortolani A, Manenti F, Isaakidis P, Putoto G, et al. Breast tuberculosis in men: A systematic review. PLoS One 2018; 13: e0194766. (PMID: 29614082) [Crossref]
  • 14. Hoda SA, Brogi E, Koerner FC, Rosen PP. Rosen’s breast pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
  • 15. Mihalache D, Giuşcă SE, Balan R, Amălinei C, Grigoraş A, Căruntu ID. A morphometric approach in breast cytology - Geometrical descriptors in the differentiation between benign and malignant lesions. Rom J Morphol Embryol 2014; 55: 273-277. (PMID: 24969974) [Crossref]
  • 16. Pandya AN, Shah NP. Breast fine needle aspiration cytology reporting: A study of application of probabilistic approach. Ind Med Gaz 2013; 147: 54-59. [Crossref]
  • 17. Arul P, Masilamani S, Akshatha C. Fine needle aspiration cytology of atypical (C3) and suspicious (C4) categories in the breast and its histopathologic correlation. J Cytol 2016; 33: 76-79. (PMID: 27279682) [Crossref]
  • 18. MacIntosh RF, Merrimen JL, Barnes PJ. Application of the probabilistic approach to reporting breast fine needle aspiration in males. Acta Cytol 2008; 52: 530-534. (PMID: 18833813) [Crossref]
  • 19. Ramji AN. Fibrocystic disease of the male breast: A case report and literature review of the rare entity. Int J Med Rev Case Rep 2019; 3: 533- 534. [Crossref]
  • 20. Pailoor K, Fernandes H, Cs J, Marla NJ, Keshava SM. Fine needle aspiration cytology of male breast lesions - A retrospective study over a six year period. J Clin Diagn Res 2014; 8: FC13-FC15. (PMID: 25478347) [Crossref]
  • 21. Robertson KE, Kazmi SA, Jordan LB. Female-type fibrocystic disease with papillary hyperplasia in a male breast. J Clin Pathol 2010; 63: 88-89. (PMID: 20026704) [Crossref]
  • 22. Shabb NS, Boulos FI, Abdul-Karim FW. Indeterminate and erroneous fine-needle aspirates of breast with focus on the ‘true gray zone’: A review. Acta Cytol 2013; 57: 316-331. (PMID: 23860443) [Crossref]
  • 23. Nascimento M, Portela A, Espada F, Fonseca M. Bloody nipple discharge in infancy—Report of two cases. BMJ Case Rep 2012; 2012: bcr2012006649. (PMID: 22814989) [Crossref]
  • 24. Yitta S, Singer CI, Toth HB, Mercado CL. Sonographic appearances of benign and malignant male breast disease with mammographic and pathologic correlation. J Ultrasound Med 2010; 29: 931-947. (PMID: 20498468) [Crossref]
  • 25. Hoda RS, Arpin III RN, Gottumukkala RV, Hughes KS, Ly A, Brachtel EF. Diagnostic value of fine-needle aspiration in male breast lesions. Acta Cytol 2019; 63: 319-327. (PMID: 30904908) [Crossref]
  • 26. Tangerud A, Potapenko I, Skjerven HK, Stensrud MJ. Radiologic evaluation of lumps in the male breast. Acta Radiol 2016; 57: 809-814. (PMID: 26543053) [Crossref] 111 Mondal and Mandal. Cytopathology of Male Breast
  • 27. Barr JG, Clayton ESJ, Sotheran W. A case of metaplastic breast cancer in a man. J Surg Case Rep 2013; 2013: rjs047. (PMID: 24964410) [Crossref]
  • 28. Ingle AP, Kulkarni AS, Patil SP, Kumbhakarna NR, Bindu RS. Mucinous carcinoma of the male breast with axillary lymph node metastasis: Report of a case based on fine needle aspiration cytology. J Cytol 2012; 29: 72 74. (PMID: 22438625) [Crossref]
  • 29. WHO classification of tumours editorial board, editors. WHO classification of tumours: Breast tumours. 5th ed, vol 2. Lyon: IARC Press; 2019.
  • 30. Joshi D, Singh P, Zonunfawni Y, Gangane N. Metaplastic carcinoma of the breast: Cytological diagnosis and diagnostic pitfalls. Acta Cytol 2011; 55: 313-318. (PMID: 21791899) [Crossref]
APA MONDAL K, MANDAL R (2021). Cytological Evaluation of Pathological Male Breast Lesions. , 103 - 111. 10.4274/ejbh.galenos.2020.6154
Chicago MONDAL KRISHNENDU,MANDAL RUPALI Cytological Evaluation of Pathological Male Breast Lesions. (2021): 103 - 111. 10.4274/ejbh.galenos.2020.6154
MLA MONDAL KRISHNENDU,MANDAL RUPALI Cytological Evaluation of Pathological Male Breast Lesions. , 2021, ss.103 - 111. 10.4274/ejbh.galenos.2020.6154
AMA MONDAL K,MANDAL R Cytological Evaluation of Pathological Male Breast Lesions. . 2021; 103 - 111. 10.4274/ejbh.galenos.2020.6154
Vancouver MONDAL K,MANDAL R Cytological Evaluation of Pathological Male Breast Lesions. . 2021; 103 - 111. 10.4274/ejbh.galenos.2020.6154
IEEE MONDAL K,MANDAL R "Cytological Evaluation of Pathological Male Breast Lesions." , ss.103 - 111, 2021. 10.4274/ejbh.galenos.2020.6154
ISNAD MONDAL, KRISHNENDU - MANDAL, RUPALI. "Cytological Evaluation of Pathological Male Breast Lesions". (2021), 103-111. https://doi.org/10.4274/ejbh.galenos.2020.6154
APA MONDAL K, MANDAL R (2021). Cytological Evaluation of Pathological Male Breast Lesions. European Journal of Breast Health, 17(2), 103 - 111. 10.4274/ejbh.galenos.2020.6154
Chicago MONDAL KRISHNENDU,MANDAL RUPALI Cytological Evaluation of Pathological Male Breast Lesions. European Journal of Breast Health 17, no.2 (2021): 103 - 111. 10.4274/ejbh.galenos.2020.6154
MLA MONDAL KRISHNENDU,MANDAL RUPALI Cytological Evaluation of Pathological Male Breast Lesions. European Journal of Breast Health, vol.17, no.2, 2021, ss.103 - 111. 10.4274/ejbh.galenos.2020.6154
AMA MONDAL K,MANDAL R Cytological Evaluation of Pathological Male Breast Lesions. European Journal of Breast Health. 2021; 17(2): 103 - 111. 10.4274/ejbh.galenos.2020.6154
Vancouver MONDAL K,MANDAL R Cytological Evaluation of Pathological Male Breast Lesions. European Journal of Breast Health. 2021; 17(2): 103 - 111. 10.4274/ejbh.galenos.2020.6154
IEEE MONDAL K,MANDAL R "Cytological Evaluation of Pathological Male Breast Lesions." European Journal of Breast Health, 17, ss.103 - 111, 2021. 10.4274/ejbh.galenos.2020.6154
ISNAD MONDAL, KRISHNENDU - MANDAL, RUPALI. "Cytological Evaluation of Pathological Male Breast Lesions". European Journal of Breast Health 17/2 (2021), 103-111. https://doi.org/10.4274/ejbh.galenos.2020.6154